Price
CHART BY
Frequently asked questions
What is Certara's market capitalization?
The market capitalization of Certara is $1.34B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Certara's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Certara is 124.78. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Certara?
Certara's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.0674. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Certara's stock?
Currently, 13 analysts cover Certara's stock, with a consensus target price of $13.50. Analyst ratings provide insights into the stock's expected performance.
What is Certara's revenue over the trailing twelve months?
Over the trailing twelve months, Certara reported a revenue of $415.55M.
What is the EBITDA for Certara?
Certara's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $102.33M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Certara?
Certara has a free cash flow of $115.71M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Certara have, and what sector and industry does it belong to?
Certara employs approximately 1,546 people. It operates in the Health Care sector, specifically within the Packaged Software industry.
What is the free float of Certara's shares?
The free float of Certara is 115.63M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $1.34B
- EPS (TTM)
- $0.0674
- Free Float
- 115.63M
- P/E ratio (TTM)
- 124.78
- Revenue (TTM)
- $415.55M
- EBITDA (TTM)
- $102.33M
- Free Cashflow (TTM)
- $115.71M
Pricing
- 1D span
- $8.193$8.454
- 52W span
- $8.135$15.69
Analyst Ratings
The price target is $13.50 and the stock is covered by 13 analysts.
Buy
6
Hold
7
Sell
0
Information
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.
- Employees
- 1,546
- Industries
- Packaged Software
- Sector
- Health Care
Identifier
- Primary Ticker
- CERT
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet